LEADER 01446nam  2200385 a 450 
001 9910701752903321
005 20120425120118.0
035   $a(CKB)5470000002420569
035   $a(OCoLC)789148007
035   $a(EXLCZ)995470000002420569
100   $a20120425d2011      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAdvocates in Research Working Group$b[electronic resource] $erecommendations /$fNational Cancer Institute, Office of the Director
210  1$a[Bethesda, Md.?] :$cU.S. Dept. of Health and Human Services, National Institutes of Health,$d[2011]
215   $a1 online resource (i, 17 pages)
225 1 $aNIH publication ;$vno. 11-7687
300   $aTitle from PDF cover (viewed Apr. 25, 2012).
300   $a"Printed March 2011"--p. [4] of cover.
517   $aAdvocates in Research Working Group 
606   $aCancer$xResearch$xGovernment policy$zUnited States
606   $aCancer$xResearch$zUnited States$xEvaluation
615  0$aCancer$xResearch$xGovernment policy
615  0$aCancer$xResearch$xEvaluation.
712 02$aNational Cancer Institute (U.S.).$bOffice of the Director.
712 02$aNational Institutes of Health (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910701752903321
996   $aAdvocates in Research Working Group$93483490
997   $aUNINA